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pACC WHITE PAPER1475CMR in Myocarditisatthias G. Friedrich, Udo Sechtem, Jeanette Schulz-Menger, Godtfred Holmvang, Pauline Alakija,
eslie T. Cooper, James A. White, Hassan Abdel-Aty, Matthias Gutberlet, Sanjay Prasad, Anthony Aletras,
ean-Pierre Laissy, Ian Paterson, Neil G. Filipchuk, Andreas Kumar, Matthias Pauschinger, Peter Liu,
or the International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis
urrently, no single clinical or imaging finding confirms the diagnosis of myocarditis; rather,
n integrated synopsis including history, clinical assessment, and noninvasive testing should be
sed. Cardiovascular magnetic resonance (CMR) has emerged as the primary tool for
oninvasive assessment of myocardial inflammation. In this paper, the International
onsensus Group on Cardiovascular MR in Myocarditis articulates a set of recommendations
nd guidelines including CMR protocol standards, terminology for reporting CMR findings,
nd diagnostic CMR criteria for myocarditis. This consensus is summarized as the “Lake
ouise Criteria.”CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY14885-Year Follow-Up of the SIRIUS Trialiora Weisz, Martin B. Leon, David R. Holmes, Jr, Dean J. Kereiakes, Jeffrey J. Popma, Paul S. Teirstein,
idney A. Cohen, Hong Wang, Donald E. Cutlip, Jeffrey W. Moses
he SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial was a
ouble-blind, randomized study demonstrating that sirolimus-eluting stents (SES)
ignificantly improved angiographic results at 8 months and clinical outcomes at 1 year
ompared with bare-metal stents (BMS) in patients with relatively simple de novo coronary
esions. This report extends the follow-up period to 5 years. Between 1 and 5 years,
dditional clinical events were similarly distributed among the SES and BMS cohorts, and
he reduction in target lesion revascularization remained significant. The benefits in reduced
estenosis with SES are maintained over 5 years with no evidence of late hazard in this
atient group.(continued on page A-23)
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aNTERVENTIONAL CARDIOLOGY1498Acute Hemodynamic Effects of Primary PCIaurice Remmelink, Krischan D. Sjauw, José P. S. Henriques, Marije M. Vis, René J. van der Schaaf,
arel T. Koch, Jan G. P. Tijssen, Robbert J. de Winter, Jan J. Piek, Jan Baan, Jr
emmelink and colleagues studied the acute hemodynamic effects of primary percutaneous
oronary intervention (PCI) by placing a pressure-volume loop recorder into the left ventricle
LV) from the contralateral femoral artery in patients presenting with acute ST-segment
levation myocardial infarction (STEMI) secondary to left anterior descending occlusion.
mmediately after the vessel was opened, there were significant improvements in LV diastolic
unction, as indicated by a downward shift of the compliance curve. There were also decreases
n end-diastolic pressure, stiffness, and wall stress. Systolic function showed an immediate
mprovement in apical contractility. Primary PCI in anterior STEMI patients results in an
lmost instantaneous improvement in diastolic function.NTERVENTIONAL CARDIOLOGY1503Q Waves on Initial ECG Identify High-Risk STEMI Patientsaul W. Armstrong, Yuling Fu, Cynthia M. Westerhout, Michael P. Hudson, Kenneth W. Mahaffey,
arvey D. White, Thomas G. Todaro, Peter X. Adams, Philip E. G. Aylward, Christopher B. Granger
rmstrong and colleagues compared the predictive ability of baseline Q waves and time from
ymptom onset to identify increased risk in patients presenting with ST-segment elevation
yocardial infarction (STEMI). The presence of baseline Q waves was associated with a 2.5
imes greater risk for a composite end point of death, congestive heart failure, or cardiogenic
hock. After multivariable adjustment, baseline Q-wave, but not time from symptom onset,
as significantly associated with increased risk. Baseline Q waves in STEMI patients provide
n independent prognostic marker of clinical outcome that may be more powerful than time
rom symptom onset.ORONARY ARTERY DISEASE1510Ranolazine: Safe and Effective for Patients With Chronic Anginaean R. Wilson, Benjamin M. Scirica, Eugene Braunwald, Sabina A. Murphy,
wa Karwatowska-Prokopczuk, Jacqueline L. Buros, Bernard R. Chaitman, David A. Morrow
he MERLIN–TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in
on–ST-segment Elevation Acute Coronary Syndromes) 36 trial randomized high-risk acute
oronary syndrome (ACS) patients to ranolazine or placebo. There was no significant
ifference in the primary end point of major cardiovascular events. In this pre-specified
ubgroup analysis, Wilson and colleagues evaluated the efficacy and safety in 3,500
andomized subjects who had chronic angina prior to their presentation with ACS. There
ere no significant differences in the rates of cardiovascular death or myocardial infarction,
ut recurrent ischemia was substantially reduced and exercise duration improved. Ranolazine
ppears to be effective in reducing angina with a favorable safety profile.(continued on page A-26)
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iORONARY ARTERY DISEASE1517Microvessels in Atherosclerotic Plaques Show Compromised Structural IntegrityEditorial Comment
Sebastian F. Mause andudith C. Sluimer, Frank D. Kolodgie, Ann P. J. J. Bijnens, Kimberly Maxfield, Erica Pacheco, Bob Kutys,
ans Duimel, Peter M. Frederik, Victor W. M. van Hinsbergh, Renu Virmani, Mat J. A. P. Daemen
ntraplaque and adventitial angiogenesis are known to influence the risk of plaque rupture and
tenosis severity, but this process remains poorly understood. Sluimer and colleagues examined
he ultrastructure of microvessels in normal and atherosclerotic coronary arteries from autopsy
pecimens. Microvessel density (MVD) was increased in advanced plaques compared with
arly plaques. Intraplaque microvascular endothelial cells (ECs) were abnormal, with
embrane blebs, intracytoplasmic vacuoles, open EC-EC junctions, and basement membrane
etachment. MVD is associated with coronary plaque progression and morphology and the
ompromised structural integrity of microvascular endothelium may lead to intraplaque
emorrhage.ARDIAC PHARMACOLOGY1532Nebivolol Activates Ventricular  -Adrenoceptors, Acts as Negative InotropeEditorial Comment3
ertrand Rozec, Mortéza Erfanian, Karine Laurent, Jean-Noël Trochu, Chantal Gauthier
3-adrenoceptor (AR) stimulation produces a negative inotropic effect opposite to that
nduced by 1- and 2-AR activation; 3-AR stimulation might play a role as a “safety-valve”
uring intense adrenergic stimulation. Rozec and colleagues studied the effect of nebivolol and
3-ARs in isolated endomyocardial biopsy samples attached to a mechanoelectric force
ransducer. Nebivolol induced a concentration-dependent decrease in peak tension; this effect
as blunted in the presence of a 3-AR antagonist and after pre-treatment with a nitric oxide
ynthase inhibitor. These results suggest that nebivolol activates 3-AR in human ventricles
roducing a nitric oxide-dependent negative inotropic effect.ARDIAC IMAGING1543RT 3D TEE for Suspected Mitral Valve Dehiscencetzhak Kronzon, Lissa Sugeng, Gila Perk, David Hirsh, Lynn Weinert, Miguel Angel Garcia Fernandez,
oberto M. Lang
he diagnosis of post-operative mitral valve dehiscence is generally performed using 2-
imensional (2D) transthoracic and transesophageal echocardiography. Recently, a real-time
-dimensional (RT 3D) transesophageal echocardiography (TEE) probe has been developed.
ronzon and colleagues describe the use of this probe in 18 patients suspected of having
ost-operative mitral ring dehiscence. RT 3D TEE allowed accurate evaluation of the
athology including the site, size, shape, and area of the dehisced segment. In suspected
itral valve dehiscence, RT 3D TEE may be useful in planning the appropriate corrective
ntervention.(continued on page A-28)
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cONGENITAL HEART DISEASE IN THE ADULT1548CPET Predicts Outcomes in Patients With Previous M/S OperationEditorial Commentlessandro Giardini, Alfred Hager, Astrid E. Lammers, Graham Derrick, Jan Müller, Gerhard-Paul Diller,
onstantinos Dimopoulos, Dolf Odendaal, Gaetano Gargiulo, Fernando M. Picchio, Michael A. Gatzoulis
or many years, the standard treatment for patients with transposition of the great arteries
as the Mustard and Senning (M/S) operation. Giardini and colleagues have been
erforming cardiopulmonary exercise testing (CPET) on all M/S patients who can exercise as
art of their routine clinical practice. This paper reviews whether CPET can be used to
redict death or cardiac-related hospitalizations. Ventilation per unit of carbon dioxide output
VE/VCO2) and percentage of predicted peak oxygen uptake (VO2%) were both strong
redictors of adverse outcomes in a multivariable model with high hazard ratios. CPET
rovides important prognostic information in adults who had an M/S operation as an infant.YEAR IN CARDIOLOGY SERIES EAR IN CARDIOLOGY SERIES1558The Year in Echocardiographyrthur E. Weyman
eyman reviews the latest literature regarding the use of echocardiography. Topics
ddressed include the different techniques available for the assessment of patients for
ardiac resynchronization therapy and for the assessment of diastolic parameters. He
oncludes with recently published articles that suggest that echocardiographic
ontrast is safe for clinical use.
